Literature DB >> 15861487

US28 actions in HCMV infection: lessons from a versatile hijacker.

J M Boomker1, M J A van Luyn, T H The, L F M H de Leij, M C Harmsen.   

Abstract

Mimicking host proteins is a strategy adopted by several herpesviruses to exploit the host cell for their own benefit. In this respect the human cytomegalovirus (HCMV) chemokine receptor homologue US28, has been extensively studied. Molecular pirates such as US28 can teach us about crucial events in HCMV infection and may either offer a potential target for antiviral therapy or provide an alternative strategy to immune suppression. Despite elaborate research into the chemokine binding affinity, signalling properties, intracellular trafficking and expression kinetics of US28, a solid hypothesis about the role of US28 in HCMV infection has not yet been proposed. It appears that US28 may behave as a molecular pirate that employs smart strategies for cell entry, host gene regulation and immune evasion. This review will elaborate on these aspects of US28 biology and discuss possible implications for HCMV infection. Copyright (c) 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15861487     DOI: 10.1002/rmv.468

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  3 in total

1.  Meeting of conventional and unconventional pathways at the TGN.

Authors:  Gaudeline Rémillard-Labrosse; Roger Lippé
Journal:  Commun Integr Biol       Date:  2009-09

Review 2.  US28, a Virally-Encoded GPCR as an Antiviral Target for Human Cytomegalovirus Infection.

Authors:  Sungjin Lee; Yoon Hee Chung; Choongho Lee
Journal:  Biomol Ther (Seoul)       Date:  2017-01-01       Impact factor: 4.634

Review 3.  Human cytomegalovirus encoded homologs of cytokines, chemokines and their receptors: roles in immunomodulation.

Authors:  Brian P McSharry; Selmir Avdic; Barry Slobedman
Journal:  Viruses       Date:  2012-10-25       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.